Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

NCT06861010 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Diseases

Interventions

OTHER: Placebo
DRUG: Ondansetron

Sponsor

Tanta University